CN Patent

CN113950479A — 作为syk抑制剂的缩合吡嗪的固体形式

Assigned to Cronos Biology Co ltd · Expires 2022-01-18 · 4y expired

What this patent protects

制备和表征了化合物6‑(6‑氨基吡嗪‑2‑基)‑N‑(4‑(4‑(氧杂环丁烷‑3‑基)哌嗪‑1‑基)苯基)咪唑并[1,2‑a]吡嗪‑8‑胺的固体形式以及化合物I的盐的固体形式或共晶体：(式I)。还提供制备该固体形式的过程及其使用方法。

USPTO Abstract

制备和表征了化合物6‑(6‑氨基吡嗪‑2‑基)‑N‑(4‑(4‑(氧杂环丁烷‑3‑基)哌嗪‑1‑基)苯基)咪唑并[1,2‑a]吡嗪‑8‑胺的固体形式以及化合物I的盐的固体形式或共晶体：(式I)。还提供制备该固体形式的过程及其使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN113950479A
Jurisdiction
CN
Classification
—
Expires
2022-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Cronos Biology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.